IL-17 Expression in Perifollicular Fibrosis in Biopsies from Lichen Planopilaris
September 2022
in “
The American Journal of Dermatopathology
”
Studysummary This study found that IL-17 expression was significantly higher in perifollicular fibrosis of active Lichen planopilaris lesions, suggesting that targeting IL-17 could impact the disease's progression.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study "IL-17 Expression in the Perifollicular Fibrosis in Biopsies From Lichen Planopilaris" by Miteva et al. examined the expression of IL-17 in scalp biopsies from 40 patients with active Lichen planopilaris (LPP), a type of hair loss for which there is currently no cure. The researchers found a significant increase in IL-17 expression in the perifollicular fibrosis of the affected follicles in LPP compared to 20 control biopsies from patients with chronic telogen effluvium (P < 0.0001). The cells expressing IL-17 were identified as fibroblasts. The study concludes that blocking the IL-17 inflammatory pathway may interfere with the progression of the perifollicular fibrosis and inflammation in LPP, suggesting a potential new treatment approach.